Does the acquisition have the potential to expand the global availability of the EnSeal product line? Do Ethicon Endo-Surgery and SurgRx share a commitment to innovation for the surgeons and patients who depend on our products? Will the combination of HARMONIC and EnSeal technologies position them to better address many different procedure needs?
IIP > read on here > http://www.prnewswire.com…
…Ethicon Endo-Surgery announced today that it has entered into a definitive agreement to acquire SurgRx, a privately held developer of the advanced bipolar tissue sealing system used in the EnSeal(R) family of devices. The acquisition will provide Ethicon Endo-Surgery with a new energy platform, which complements its HARMONIC(R) line of ultrasonic medical devices that have been used to perform open and laparoscopic procedures worldwide. Terms of the agreement were not disclosed. The transaction is subject to customary clearances, including the Hart-Scott-Rodino AntitrustImprovements Act and similar regulations in other countries…
SurgRx was founded in 2002 and is located in Redwood City, Calif. The EnSeal(R) family of devices combines high compression and controlled energy delivery to quickly create strong vessel seals. The EnSeal(R) device, cleared by the FDA in 2003, is capable of sealing vessels up to 7mm in diameter…
Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at http://www.ethiconendo.com…